resourced, I appreciate your angst at seeing a large part of your capital evaporate over the last week.
The answers to your finanicial questions won't generally be forthcoming until reimbursements are approved. I think this is fair enough; suffice it to know that royalty revenue is roughly double for assuming risk in lieu of an upfront sign-on bonus. Honestly, you should be able to figure out approximate revenues just knowing the business plan for the next 2 years.
Unfortunately, you don't. However, it sounds like, because the agreement was formalised the day before the AGM, they didn't have anything substantive to announce other than slides taken from the EOI that Quintiles must have put together for TIS to win the partnership agreement.
Take Monday's announcement as "We didn't sign a deal with a big pharma, and we're going it alone for the meantime with a bit of consulting help."
My guess is that you'll wait another month for a business plan update. Sorry. Takeover offers will not likely be forthcoming unless hostile during a period of SP depression, because management wants so much royalty that there isn't much incentive for a pharma to assume the business risk.
Add to My Watchlist
What is My Watchlist?